Literature DB >> 8692714

The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.

V Gotzos1, P Vogt, M R Celio.   

Abstract

In a series of 23 cases of mesothelioma of either the epithelial, sarcomatoid or the mixed type, the expression of three calcium-binding proteins (calretinin, parvalbumin and calbindin-D28k) was studied using immunohistochemical techniques on paraffin sections. The results show that calretinin is expressed in mesotheliomas of the epithelial type (papillary, adenomatous or solid) and by the epithelial component of the mixed tumours. The immunohistochemical reaction is specific and reproducible. The tissues of the pulmonary parenchyma and of the pleura are negative for calretinin except for the rare fibroblasts and some skeletal muscle fibres situated in the interstices of, or near the epithelial tumour mass. The sarcomatoid mesotheliomas and the sarcomatoid component of the mixed tumours do not express calretinin. Parvalbumin and calbindin-D28k are expressed neither in mesotheliomas nor in normal lung tissue. Primary adenocarcinomas of the lung are negative for all three calcium binding proteins cited. Thus, calretinin seems to represent a selective marker for mesotheliomas of the epithelial type and allows their differentiation from metastases of lung adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692714     DOI: 10.1016/S0344-0338(96)80208-1

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  19 in total

1.  E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.

Authors:  Dong-Nan He; Hua-Sheng Zhu; Kun-He Zhang; Wen-Jian Jin; Wei-Ming Zhu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.

Authors:  Marie-Marthe Philippeaux; Jean-Claude Pache; Sophie Dahoun; Marc Barnet; John-Henri Robert; Jacques Mauël; Anastase Spiliopoulos
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

Review 3.  Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

Authors:  Sinchita Roy Chowdhuri; Patricia Fetsch; Jennifer Squires; Elise Kohn; Armando C Filie
Journal:  Diagn Cytopathol       Date:  2012-11-16       Impact factor: 1.582

Review 4.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

5.  TLE1 expression in malignant mesothelioma.

Authors:  Atsuji Matsuyama; Masanori Hisaoka; Mahoko Iwasaki; Mao Iwashita; Sachi Hisanaga; Hiroshi Hashimoto
Journal:  Virchows Arch       Date:  2010-09-21       Impact factor: 4.064

6.  Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.

Authors:  Irina Raiko; Ingrid Sander; Daniel G Weber; Monika Raulf-Heimsoth; Adrian Gillissen; Jens Kollmeier; Arnaud Scherpereel; Thomas Brüning; Georg Johnen
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

7.  Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.

Authors:  Helmut P Sandeck; Oluf D Røe; Kristina Kjærheim; Helena Willén; Erik Larsson
Journal:  Diagn Pathol       Date:  2010-07-06       Impact factor: 2.644

8.  SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis.

Authors:  Thomas Henzi; Walter-Vincent Blum; Martine Pfefferli; Tadeusz J Kawecki; Valerie Salicio; Beat Schwaller
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

Review 9.  Cytosolic Ca2+ Buffers Are Inherently Ca2+ Signal Modulators.

Authors:  Beat Schwaller
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-01-02       Impact factor: 10.005

Review 10.  DNA repair and damage pathways in mesothelioma development and therapy.

Authors:  Faezeh Malakoti; Niloufar Targhazeh; Erfan Abadifard; Reza Zarezadeh; Sahar Samemaleki; Zatollah Asemi; Simin Younesi; Reza Mohammadnejad; Seyed Hadi Hossini; Ansar Karimian; Forough Alemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-05-02       Impact factor: 6.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.